Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mouse Human Purity mixing studies

ABSTRACT: We used human + mouse cell mixtures to demonstrate the purity of PIP-seq single cell RNA-sequencing

ORGANISM(S): Mus musculus Homo sapiens

PROVIDER: GSE202911 | GEO | 2023/01/12

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Impact of post-lysis stopping point prior to reverse transcription

Project description:We used human + mouse cell mixtures to demonstrate the purity of PIP-seq single cell RNA-sequencing

2023-01-12 | GSE215064 | GEO

Cross-Platform Comparison

Project description:We used human + mouse cell mixtures to demonstrate the purity of PIP-seq single cell RNA-sequencing

2023-01-12 | GSE215062 | GEO

Mouse Human Purity mixing studies

Project description:Mouse Human Purity mixing studies

| PRJNA902363 | ENA

MethylPurify: tumor purity deconvolution and differential methylation detection from tumor DNA methylomes

Project description:We propose a statistical algorithm MethylPurify that uses regions with bisulfite reads showing discordant methylation levels to infer tumor purity from tumor samples alone. With purity estimate, MethylPurify can identify differentially methylated regions (DMRs) from individual tumor samples without genomic variation information or prior knowledge from other datasets. In simulations with mixed bisulfite reads from cancer and normal cell lines, MethylPurify correctly inferred tumor purity and identified over 96% of the DMRs. On real patient data where tumor to normal comparison were used as golden standard, MethylPurify called DMR from tumor samples alone at over 57% sensitivity and 91% specificity.

2014-07-08 | GSE56712 | GEO

VeraCode GoldenGate Methylation Assay microarray data for purified human leukocytes, reconstruction mixtures and human whole blood samples

Project description:The objective of the study was to utilize DNA methylation to quantify human leukocyte subsets in human blood. This file contains data from an Illumina custom VeraCode GGMA microarray for human leukocyte subtypes (purified from whole blood samples via magnetic activated cell sorting (MACS) and purity confirmed by flourescence activated cell sorting (FACS)) as well as for complex mixtures of DNA from those samples, and for human whole blood samples.

2014-02-04 | GSE54647 | GEO

The tetraspanin CD9 affords high purity capture of all murine hematopoietic stem cells.

Project description:Prospective isolation is critical to understand the cellular and molecular aspects of stem cell heterogeneity. Here we identify the cell surface antigen CD9 as a novel positive marker that provides a simple alternative for hematopoietic stem cell-isolation at high purity

2013-09-01 | GSE47707 | GEO

MethylPurify: tumor purity deconvolution and differential methylation detection from tumor DNA methylomes

2014-07-08 | E-GEOD-56712 | biostudies-arrayexpress

Quality control measures for placental sample purity in DNA methylation array analyses

Project description:The purity of tissue samples can affect the accuracy and utility of DNA methylation array analyses. This is particularly important for the placenta which is hypomethylated. Placental villous tissue from early pregnancy terminations can be difficult to separate from the non-villous tissue, resulting in potentially inaccurate results. We used several methods to identify mixed placental samples using DNA methylation array datasets from our laboratory and those contained in the NCBI GEO database, highlighting the importance of determining sample purity during quality control processes.

2020-06-09 | GSE131945 | GEO

Purity Independent Subtyping of Tumors (PurIST), a clinically robust single sample classifier for tumor subtyping in pancreatic cancer (NanoString)

Project description:We assess three major subtype classification schemas in the context of results from two clinical trials and by meta-analysis of publicly available expression data to assess statistical criteria of subtype robustness and overall clinical relevance. We then developed a Single Sample Classifier (SSC) using penalized logistic regression based on the most robust and replicable schema. We demonstrate that a tumor-intrinsic two subtype schema is most robust, replicable, and clinically relevant. We developed purity independent subtyping of tumors (PurIST), a SSC with robust and highly replicable performance on a wide range of platforms and sample types. We show that PurIST subtypes have meaningful associations with patient prognosis and have significant implications for treatment response to FOLIFIRNOX. Keywords: Expression profiling by array

2020-02-21 | GSE131051 | GEO